Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Science Advances|March 13, 2026
IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cellsErin B Cole, Sara Lamcaj, Agnes V Sydenstricker, et al.Frontiers in Immunology|October 29, 2021
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin LymphomaPaolo F Caimi, Gabriela Pacheco Sanchez, Ashish Sharma, et al.Journal of Translational Medicine|July 16, 2026
Development of a 3-day manufacturing method to generate CD19-CD20-CD22 trispecific CAR T-cells from whole bloodIsabella Vignola, Michaela Prochazkova, Lipei Shao, et al.Frontiers in Immunology|August 28, 2020
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin LymphomaZachary Jackson, Anne Roe, Ashish Arunkumar Sharma, et al.Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.Nature Medicine|November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapyTerry J Fry, Nirali N Shah, Rimas J Orentas, et al.Cancer Immunology, Immunotherapy : CII|October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cellsTamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.Cancer Immunology, Immunotherapy : CII|December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cellsTamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.Eclinicalmedicine|March 21, 2025
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trialArmin Ghobadi, Paolo F Caimi, Jane S Reese, et al.Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.Pageof 5